Respiratory

Latest News

FDA Approves Tezspire in Pre-Filled Pen
FDA Approves Tezspire in Pre-Filled Pen

February 3rd 2023

Tezspire is a biologic that specifically targets the inflammation associated with asthma.

FDA Approves Rescue Combination Medication for Asthma
FDA Approves Rescue Combination Medication for Asthma

January 11th 2023

FDA Accepts BLA for RSV Prevention in Infants
FDA Accepts BLA for RSV Prevention in Infants

January 5th 2023

FDA Accepts for Priority Review BLA for RSV Vaccine
FDA Accepts for Priority Review BLA for RSV Vaccine

December 7th 2022

 FDA Approves Orkambi for Expanded Use in Children with Cystic Fibrosis
FDA Approves Orkambi for Expanded Use in Children with Cystic Fibrosis

September 4th 2022

More News

© 2023 MJH Life Sciences

All rights reserved.